News

It was expected that Oporia would be a big selling drug for Pfizer with annual sales estimated up to $1 billion. The application for Oporia, a selective estrogen

The drug produced a significant improvement in blood pressure and arterial stiffness in patients at risk of cardiovascular events such as heart attack and stroke, but with no

The advisory committee chose not to recommend Xinlay (atrasentan) for the treatment of patients with hormone-refractory prostate cancer (HRPC) that has spread to the bone but did say

Mouse Specifics analyzed the gait of animals with Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS) using a high speed digital imaging system. Mice were placed on

Until recently, intrauterine devices (IUD) were only recommended for women in mutually monogamous relationships with at least one child. Now, the FDA has approved the hormone-free ParaGard as

Aromasin (exemestane) is a hormonal therapy, used to treat women with breast cancers that depend on a hormone, specifically estrogen, for growth and survival. An estimated two-thirds of

Initially, the companies will focus on Novavax’s H9N2 avian flu virus-like particle vaccine that has shown promising results in preclinical studies. Wave Biotech will provide process and equipment

The companies will now be able to use the research conducted at Stanford University to discover and develop new therapeutic products for the treatment of the disease. According

The company is planning on testing two doses of its wound healing agent, Cardio Vascu-Grow, for topical application. The principal purpose of this first study is to test